← Back to all substances

A nootropic drug of the racetam class, originally developed to treat Alzheimer's disease, it is currently being investigated as a treatment for major depressive disorder and generalised anxiety disorder. May be a modulator of the AMPA receptor. Limited recreational value.

Dosage

Insufflated

Common: 5-10mg
Light: 2-5mg
Strong: 10mg+

Oral

Common: 5-10mg
Light: 3-5mg
Strong: 10-20mg+

Sublingual

Common: 5-10mg
Light: 2-5mg
Strong: 10mg+

Duration

Onset: undefined minutes
Duration: 3-6 hours
After effects: 1-4 hours

Timeline

Peak
3-6 hours
After
1-4 hours
05h10h
Typical
Extended range

External Links